News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-12-22 4:31:12 am Cidara Therapeutics Announces European Approval of REZZAYO® (rezafungin) for the Treatment of Invasive Candidiasis in Adults GlobeNewsWire
2023-12-07 5:0:0 am Cidara Therapeutics Presents New Promising Preclincal Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress GlobeNewswire
2023-12-06 5:0:0 am Cidara Therapeutics Announces Completion of Enrollment in Phase 3 Restore Trial of Rezafungin in China GlobeNewswire
2023-11-30 5:0:0 am Cidara Therapeutics to Present New Preclinical Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress GlobeNewswire
2023-11-20 5:0:0 am Cidara Therapeutics Named as a San Diego Metro Area Top Workplace GlobeNewswire
2023-11-03 9:0:0 am Cidara Therapeutics Presents Preclinical Data on Novel Drug-Fc Conjugate CBO421 at SITC’s 38ᵗʰ Annual Meeting GlobeNewswire
2023-11-02 4:33:31 pm Cidara Therapeutics Inc (CDTX) Reports Q3 2023 Financial Results GuruFocus.com
2023-11-02 1:32:48 pm Cidara Therapeutics: Q3 Earnings Snapshot Associated Press Finance
2023-11-02 1:15:0 pm Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information